Efficacy of candesartan cilexetil alone or in combination with amlodipine and hydrochlorothiazide in moderate-to-severe hypertension

Hypertension

Volumn 36, Issue 3, 2000, Pages 454-460

  MacGregor, Graham A ^a   Viskoper, J Reuven ^b   Antonios, Tarek F T ^a   He, Feng J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Amlodipine; Angiotensin II receptors antagonists; Candesartan cilexetil; Hydrochlorothiazide; Hypertension, essential

Indexed keywords

AMLODIPINE; CANDESARTAN HEXETIL; HYDROCHLOROTHIAZIDE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; LETHARGY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; UPPER RESPIRATORY TRACT INFECTION; VERTIGO;

EID: 0033822489     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.36.3.454     Document Type: Article

References (16)

1. Amlodipine and lisinopril in combination for the treatment of essential hypertension: Efficacy and predictors of response
2. A diuretic is more effective than a β-blocker in hypertensive patients not controlled on amlodipine and lisinopril
3. Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo: The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents
4. Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension
5. Losartan potassium as initial therapy in patients with severe hypertension
6. Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension: Irbesartan Multicenter Investigators
7. Pharmokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers
8. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension
9. Candesartan cilexetil, a new generation angiotensin II antagonist, provides dose dependent antihypertensive effect
10. Combination therapy with candesartan cilexetil plus hydrochlorothiazide in patients unresponsive to low-dose hydrochlorothiazide
11. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: The Omron HEM-705CP, Philips HP5332, and Nissei DS-175
12. Clinical evaluation of the Accutracker II ambulatory blood pressure monitor: Assessment of performance in two countries and comparison with sphygmomanometry and intra-arterial blood pressure at rest and during exercise
13. Twenty-four hour blood pressure profile of different doses of candesartan cilexetil in patients with mild to moderate hypertension
14. Pharmacokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers
15. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects
16. Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist